Gill Denis
Children's University Hospital, Temple Street, Dublin 1, Ireland.
Eur J Pediatr. 2004 Feb;163(2):53-7. doi: 10.1007/s00431-003-1378-5. Epub 2004 Jan 10.
A child has the full right of protection of his/her life by provision of optional medical care. There is a need in paediatrics for better evidence based practice founded on quality research into efficacy and safety of children's medications. To protect the best interests of the child one must balance the ethical demand to do clinical studies with the necessity to avoid doing harm. To achieve this end good clinical practice in paediatric research demands that studies comply with the Declaration of Helsinki, ICH topic E11, EU Directives and other relevant international guidelines. Evident differences in physiology, pharmacology, pharmacokinetics and pharmacodynamics between children of differing ages and between children and adults demand properly constructed and conducted studies that respect the special somatic, emotional and mental needs of children. To justify any research project one must balance the benefit/risk ratio, provide experienced, competent personnel and infracture, obtain adequate informed consent/assent, and have the study evaluated and approved by an ethics committee containing expertise on the rights and needs of children.
儿童有权通过获得选择性医疗护理来充分保护其生命。儿科学领域需要基于对儿童药物疗效和安全性的高质量研究,形成更好的循证实践。为保护儿童的最大利益,必须在进行临床研究的伦理要求与避免造成伤害的必要性之间取得平衡。为实现这一目标,儿科研究中的良好临床实践要求研究符合《赫尔辛基宣言》、国际人用药品注册技术协调会(ICH)E11主题、欧盟指令及其他相关国际准则。不同年龄段儿童之间以及儿童与成人之间在生理学、药理学、药代动力学和药效学方面存在明显差异,这就要求开展精心设计和实施的研究,尊重儿童特殊的身体、情感和心理需求。要使任何研究项目合理可行,必须权衡利弊比,提供经验丰富、资质合格的人员和基础设施,获得充分的知情同意/同意,并由包含儿童权利和需求方面专业知识的伦理委员会对研究进行评估和批准。